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ABSTRACT
 يولكلا  روصقلا  ىضرلم  ينقاسلا  لملتم  ةمزلاتم  ديدتح   :فادهلأا
 لملتم ةمزلاتم نودب وأ عم نمزلما يولكلا روصقلا ةنراقم عم نمزلما
مونلا ةيعونو بعتلا نم ًلاك يف ينقاسلا
 ًاضيرم 220 ىلع ةيضرعلا ةيعطقلما ةساردلا هذه تلمتشا  :ةقيرطلا
 يولكلا  ليسغلل  نوعضخي  =  ماع  75  و  18  ينب  مهرامعأ  حوارتت
 رياني  نم  ةرتفلا  للاخ  ايكرت  ،موروج  ةقطنم  يف  ايعوبسأ  تارم  3
 يصيخشتلا جذومنلا ىلإ RLS صيخشت دنتسا .م-2016م 2014
 مونلا  ةدوج مييقت  تم  .ةيلودلا  RLS  ةسارد  ةعومجم هتحرتقا  يذلا
 ديدتح تمو ، Pittsburgh (PSQI(يف مونلا ةدوج رشؤم مادختساب
.(FSS( بعتلا ةدش سايقم مادختساب بعتلا ةدش
 ينباصم اوناك(ىلولأا ةعومجلما( 37=ددعلا 16.8% ينب نم  :جئاتنلا
 ةمزلاتبم ينباصم اونوكي مل ضيرم 183 امنيب ،ينقاسلا لملتم ةمزلاتبم
 يف هباشتم رامعلأا طسوتم ناك .(ةيناثلا ةعومجلما( ينقاسلا لملتم
 طقف  ننيموبلا  ناك  ،ةيربتخلما  ليلاحتلاب  قلعتي  اميفو  .ينتعومجلما
 .(p<0.05( ةيناثلا ةعومجلما يف هنم ىلولأا ةعومجلما يف ريثكب لقأ
 ،46.4%  هلدتعم  ،7.1%  يف  هفيفخ ينقاسلا  لملتم  ةمزلات  تناك
 .ينقاسلا  لملتم  ةمزلاتبم  ينباصلما  ىضرلما  نم  39.3%  يف  هديدشو
 يولكلا ليسغلا ةدمو ،نزولا RLS ةدشب ةطبترلما لماوعلا تلمتشاو
 عبشتو ،يلكلا ديدلحا طبر ىلع ةردقلاو ، ديدلحاو ،لوبلا عاطقنا ،
 يف  أوسأ  FSS  و  PSQI  تاجرد  تناك  .نيريفسنارتلاو  مويسلاكلا
.(p<0.001( ىلولأا ةعومجلما
 يذلا  ىضرلما  دنع  ةعئاش  ةلاح  ينقاسلا  لملتم  ةمزلاتم  :ةتمالخا
 ـل  ةراضلا  راثلآا  انتسارد  جئاتن  دكؤت  ،يولكلا  ليسغلل  نوعضخي
.بعتلاو مونلا ةيعون بناوج ثيح نم RLS
Objective: To determine the prevalence of restless legs 
syndrome (RLS( in patients with chronic renal failure 
(CRF( and to compare CRF patients with or without 
RLS in terms fatigue and sleep quality. 
Methods: A cross-sectional study was conducted on 220 
patients (18-75 years( who were undergoing dialysis 3 
times weekly in Çorum Province, Corum, Turkey, 
between January 2014 and January 2016. The diagnosis 
of RLS was based on the diagnostic form proposed 
by the international RLS study group. Sleep quality 
was evaluated using the Pittsburgh sleep quality index 
(PSQI(, and severity of fatigue was determined by using 
fatigue severity scale (FSS(. 
Results: Of all the participants, 16.8% (n= 37( (Group 
1( were found to have RLS, while 183 patients had no 
RLS (Group 2(. The mean ages were similar between 
groups. With respect to laboratory analyses, a p-value 
of <0.05 was considered in Group 1 than in Group 2. 
Restless legs syndrome was mild (7.1%(, moderate 
(46.4%( and severe (39.3%( in patients with RLS. 
Factors associated with the severity of RLS included 
weight, duration of dialysis, anuria, iron, total iron 
binding capacity, calcium and transferrin saturation. The 
PSQI and FSS scores were significantly worse in Group 
1 (p<0.001(. 
Conclusion: Restless legs syndrome is a common 
condition in patients undergoing hemodialysis; the 
results of our study confirm the adverse effects of RLS in 
terms of many aspects of sleep quality and fatigue. 
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Restless legs syndrome (RLS( is a neurological sensory-motor disorder that is associated with 
reduced life quality and feelings of discomfort mostly 
occurring during sleeping hours.1,2 The condition is 
characterized by an urgent, uncontrollable need to 
move one’s limbs that is accompanied by, or caused 
by, a peculiar, unpleasant sensation (paraesthesia(.3 
Moving the legs or walking usually eases the symptoms, 
which are generally more intense during the night 
hours and tend to occur at rest.2 Restless legs syndrome 
causes confusion and unrest which affects individual 
performance and family life; increases fatigue, sleep 
disturbance and stress; and reduces quality of life.4
Depending on the etiological factors, the disease 
is classified into primary and secondary forms. Most 
patients have the primary idiopathic form of the disease, 
in which a positive family history is present in nearly 
40% of the cases, suggesting a genetic predisposition.4,5 
Secondary RLS mostly occurs in association 
with iron deficiency, while other conditions, such 
as peripheral neuropathy, diabetes mellitus (DM(, 
multiple sclerosis, radiculopathy, rheumatoid arthritis, 
and renal failure may frequently co-exist with RLS.6,7 
Also, RLS may develop as a secondary condition during 
the course of several diseases, such as Parkinsonism, 
rheumatic disease or during pregnancy.1,7,8 Certain 
medications (antihypertensives, antidepressants, 
histamine receptor blockers( have also been reported 
to elicit RLS symptoms.5,9 Risk factors for RLS include 
advanced age, alcohol intake, smoking cigarettes, and 
caffeine intake.10,12 
The prevalence of RLS varies across the world. In 
western countries, an estimated 8-15% of the general 
population experiences RLS; however, less than 5% of 
the Asian population is affected.13 A previous study in 
Turkey reported a prevalence rate of 3.19%.14 
The prevalence of RLS in chronic renal failure (CRF( 
patients requiring hemodialysis (HD( is higher than 
the general population and ranges from 6.6%-70%.13 
Zaware et al reported that the prevalence of RLS in 
HD patients was 54.5% in their study on RLS and 
insomnia.4 In another study with 260 dialysis patients, 
Saraji et al found that the prevalence of RLS was 55%, 
reporting a higher mean age and duration of dialysis for 
the RLS group.15 Dikici et al conducted a study on the 
prevalence of RLS in Turkey, finding a rate of 45.9% as 
well as higher anxiety and insomnia in RLS patients.9
Restless legs syndrome is one of the leading causes 
of impaired quality of life in the general population. 
In HD patients, sleep disorders may lead to serious 
complications in the areas of mental health, general 
health, body pain, fatigue and physical functioning. The 
comorbidity of sleep disturbances and depression can 
cause severe consequences for HD patients. In addition, 
there are significant findings indicating that RLS and 
severe periodic limb-movement disorder are associated 
with increased mortality in HD patients.16,17
The objective of this study was to determine the 
prevalence of RLS in CRF patients undergoing HD 
in 2 separate centres of Corum province in Turkey. 
Also, secondary objectives included the comparison of 
demographic and biochemical characteristics as well as 
fatigue and sleep disturbance among CRF patients with 
or without RLS.
Methods. A total of 221 patients from 18-75 years 
of age undergoing dialysis 3 times weekly in 2 dialysis 
centres in Corum Province, Corum, Turkey were 
included. This cross-sectional study was carried out 
between January 2014 and January 2016, and the study 
protocol was approved by the Local Ethics Committee. 
The study was conducted according to the principles 
declaration of Helsinki, and all patients provided 
written informed consent prior to the study’s initiation. 
All CRF patients over 18 years of age with a Kt/V ratio 
of greater than 1.4 (a marker of dialysis efficacy( were 
enrolled. 
Age, duration of hemodialysis (months(, concurrent 
systemic diseases (DM, hypertension, cardiac failure(, 
cigarette smoking, coffee consumption, alcohol intake, 
haemoglobin, glucose, urea, creatinine, calcium, 
phosphorus, albumin, alkaline phosphatase, ferritin, 
parathyroid hormone, iron and total iron binding 
capacity (TIBC( were recorded. Transferrin saturation 
(TSAT( was estimated by dividing the iron level by 
the TIBC. For all biochemical analyses, sampling was 
performed 15 minutes prior to the dialysis session. 
Restless legs syndrome diagnosis were based on 
the diagnostic form developed by the international 
RLS study group (IRLSSG(. This form was originally 
developed in 1995, revised in 2002 and includes 4 
criterias, all of which should be met in order to establish 
the diagnosis.18,19 These criteria are as follows: 1( urge 
to move extremities with paraesthesia/dysesthesia; 2( 
aggravation of symptoms with rest and reduction with 
physical activity; 3( inability to stand still and relief 
of symptoms with movement (walking, stretching, 
Disclosure. Authors have no conflict of interests, and the 
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friction(; 4( worsening of symptoms during evening 
and night-time. It was noted that symptoms began after 
dialysis treatment. The severity of RLS in the patients 
was assessed with the IRLSSG. Restless legs syndrome 
severity scale, developed on the basis of the questions 
proposed by the members of the IRLSSG.20 The RLS 
severity scale contains 10 questions, each scored from 0 
(no effect of RLS( to 4 (very severe effect of RLS(. The 
total score ranges from 0-40. Questions 1, 2, 3 and 6 
are related with the severity of RLS, questions 7-8 are 
related to the frequency and intensity of the symptoms, 
questions 4-5 the effects of RLS on sleep, and questions 
9-10 measure the effect of RLS on the mood and daily 
social activities. According to scores; mild: 1-10 points, 
11-20 points, moderate: 21-30 points and severe and 
very severe RLS: 31-40 points. 
The Pittsburgh sleep quality index (PSQI( was 
used to assess sleep quality. The PSQI was originally 
developed by Buysse et al,21 and the Turkish version was 
validated by Ağargün et al.22 The PSQI is a 19-item, 
self-reported scale that measures sleep quality and 
impairment over the previous month. In addition to 
these self-reported items, 5 questions are administered 
to the spouse or roommate of the patient (for a total of 
24 questions(. The 18 questions rated by the patient 
consist of 7 components: subjective sleep quality, sleep 
latency, sleep duration, habitual sleep activity, sleep 
disturbance, use of sleep medication, and daytime 
dysfunction. Each component is assigned 0-3 points. 
The scores in each of the 7 components are added up to 
the total score, which ranges from 0-21 points. A total 
score greater than 5 points indicates ‘poor sleep quality’.
The fatigue severity scale (FSS( was used to assess 
fatigue symptoms, and the validity and reliability 
of the Turkish version was confirmed in a previous 
study.23 Using this 9-item scale, patients can assign each 
item a score between 1-7 (1= completely disagree, 7= 
completely agree(, and the total score is the average of 
all 9 items. The cut-off score for pathological fatigue 
has been set at 4 points or higher, with lower scores 
indicating less fatigue.24 
Statistical analysis. The data were summarized 
with descriptive statistics. The comparison of patients 
with or without RLS for data with normal distribution 
was performed using the Student’s t-test, while data 
without normal distribution was compared using the 
Mann-Whitney U test. Categorical data were compared 
with Chi-square and Fisher’s exact tests. The correlation 
between RLS and other parameters was assessed with 
Spearman’s analysis. A multi-regression analysis was 
performed to identify the determinants of the severity 
of RLS. A logistic regression analysis was carried out 
to find the independent variables affecting RLS. A 
p-value<0.05 was considered statistically significant.
Results. Of the overall study group of 220 
patients, 16.8% (n= 37( had RLS (Group 1(, while 
183 patients (83.2%( did not have RLS (Group 2(. 
The mean age of Group 1 was 59.31 ± 0.91 and in 
Group 2 was 61.51 ± 1.76 years, but there were no 
significant differences (p>0.05(. Also, both groups were 
comparable in terms of height, weight, body mass index 
(BMI(, (kg/m2(, age at onset of dialysis, duration of 
dialysis, concomitant diabetes and duration of diabetes 
and coexisting hypertension (p>0.05(. There were more 
smokers in Group 2. Table 1 presents the demographic 
characteristics of the patients. 
Of all the laboratory parameters tested, a p-value 
of <0.05 was considered significant only in albumin in 
the RLS group; there were no significant differences in 
the other parameters (Table 2(. Also, among the RLS 
patients, the severity of the disease was graded as mild 
(7.1%(, moderate (46.4%(, severe (39.3%( and very 
severe (7.1%(. Weight, duration of dialysis, anuria, iron 
level, total iron binding capacity (TIBC(, Calcium and 
ransferrin saturation (TSAT( were associated with the 
severity of RLS (Table 3(. 
There was a significant difference in PSQI scores 
between patients with RLS (11.41 ± 0.65( and those 
without RLS (5.68 ± 0.25( (p<0.001(. Also, all PSQI 
sub-scale scores were significantly higher in RLS patients 
(p<0.001(. The percentage of patients reporting poor 
sleep quality was 91.9% among those with RLS versus 
39.9% among those without RLS (p<0.001(. In the 
Table 1 - Demographic data of 221 patients from 18-75 years of age 
undergoing dialysis 3 times weekly in 2 dialysis centres in 
Corum Province, Corum, Turkey.
Variables RLS (n=37) No RLS(n=183) p-value
Gender F/M 25/12 87/96 0.026 c
Age 61.51±1.76 59.31±0.91 0.312 b
BMI 25.99±1.29 25.99±0.35 0.997 d
Age at first dialysis (year( 54.35±2.04 51.73±1.03 0.288 b
Duration of dialysis 6.53±0.87 7.8±0.44 0.230 b
Smoker (%( 28 (75.7( 144 (62.3( 0.814 c
Alcohol intake (%( 0 (100.0(    3   (1.6( 1.000 a
Coffee (%( 33 (89.2( 166 (90.7( 0.774 a
Anuria (%( 12 (32.4( 90 (49.1( 0.062 c
Diabetes mellitus (yes %( 21 (56.8( 114 (62.3( 0.580 c
Duration of diabetes (year( 9.95±2.29 6.51±0.78 0.162 b
Hypertension (%( 13 (35.1( 86 (47.0( 0.186 c
aFisher’s exact test, bIndependent t test, cPearson χ^2 test, 
dMann-Whitney U test. BMI - body mass index, RLS - restless legs 
syndrome
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overall group, a significant positive correlation between 
PSQI and age (r: 0.188, p<0.005( and age at first dialysis 
(r: 0.141, p<0.05( was observed; in the RSL patients, 
PSQI was significantly and positively correlated with 
the duration of diabetes (r: 0.468, p<0.05( and fatigue 
(r: 0.325, p<0.05(.
The mean FSS scores in Groups 1 was 48.3±2.29 
and 39.75±1 in Group 2,18  with a significant difference 
between the 2 groups (p<0.05( (Table 4(. Fatigue 
correlated with sleep latency (r: 0.456, p<0.05( and 
daytime dysfunction (r: 0.401, p<0.05(. The 2 groups 
were not significantly different with respect to the cause 
of CRF.
A logistic regression analysis, in which the presence 
of RLS was included as a dependent variable, was 
performed in order to determine the independent factors 
that had an impact on the risk of RLS. In multivariate 
logistic regression analyses, only the CRP value emerged 
as an independent factor for the development of RLS. 
In the univariate logistic regression analyses, gender, 
ferritin and CRP were independent factors for the 
development of RLS (Tables 5 & 6(.
Discussion. Based on the results of our study, 16.8% 
of CRF patients had RLS. There were significantly more 
smokers among the RLS patients than among patients 
without RLS. Furthermore, sleep disturbance and 
Table 2 - Comparison of laboratory data in study groups.
Laboratory data RLS (n=37) No RLS (n=183) p-value
Hb (g/dl( 14.48±2.93 11.92±0.1 0.512 d
Hct 45.15±8.66 36.21±0.33 0.466 d
Iron 54.89±3.06 61.51±2.34 0.443 d
TIBC 214.57±8.81 207.33±4.07 0.447 d
TSAT 25.08±1.80 28.18±1.05 0.283 d
TSAT < 20 (%( 21 (56.8( 115 (62.8( 0.192 c
Ferritin 644.97±50.24 631.20±25.30 0.821b
CRP 20.83±5.82 11.17±1.10 0.112 b
Albumin 4.12±0.02 5.04±0.97 0.044 d
Ca 11.39±2.55 8.86±0.07 0.968 d
P 5.76±0.93 5.07±0.07 0.338 d
PTH 379.39±39.63 389.06±21.05 0.843 b
ALP 136.13±10.82 150.99±6.71 0.339 b
Glucose 122.26±11.18 113.51±4.66 0.443 b
URR 76.48±0.74 75.03±0.45 0.215 d
Kt/V 1.74±0.05 2.84±1.20 0.668 b
bIndependent t test, cPearson χ^2 test, dMann-Whitney U test.
Kt/V: Laboratory indicators of dialysis dosage
Hb - hemoglobin, Hct - hematocrit, TIBC - total iron binding capacity, 
TSAT - transferrin saturation, CRP - C reactive protein, Ca - calcium, P - 
phosphate, PTH - parathormon, ALP - alkaline phosphatase, URR - urea 
reduction rate. 
Table 3 - Factors affecting restless legs syndrome severity scale.
Variables Multivariate regression analysis 95% CI
ß SE p-value
Constant 56.333 13.024 0.000 29.072 - 83.593
Weight -0.256 0.073 0.002 -0.409 - -0.103
Duration of 
dialysis -0.522 0.158 0.004
-0.852 - -0.192
Anuria 4.218 2.012 0.050 0.007 - 8.430
Iron -0.556 0.198 0.011 -0.970 - -0.142
TIBC 0.197 0.047 0.001 0.098 - 0.296
Ca -5.736 1.304 0.000 -8.465 - -3.007
TSAT 0.938 0.365 0.019 0.174 - 1.702
CRP -0.082 0.041 0.059 -0.168 - 0.003
R^2 =0.68. TIBC - total iron binding capacity, Ca - calcium, 
TSAT - transferrin saturation, CRP - C reactive protein.
Table 4 - Sleep and fatigue scale by groups.
Variables RLS (n=37) No RLS(n=183) p-value
PSQI 11.41±0.65 5.68±0.25 <0.001d
Poor sleep quality (no %( 3 (8.1( 111 (60.7( <0.001c
Subjective sleep quality 1.62±0.12 0.93±0.05 <0.001d
Sleep latency 2.7±0.27 1.66±0.11 <0.001d
Sleep duration 1.43±0.21 0.61±0.06 <0.001d
Habitual sleep activity 1.70±0.20 0.47±0.06 <0.001d
Sleep disturbance 1.84±0.09 1.21±0.04 <0.001d
Use of sleep medication 0.92±0.19 0.31±0.06 <0.001d
Daytime dysfunction 1.19±0.16 0.50±0.06 <0.001d
Fatigue scale 48.3±2.29 39.75±1.18 0.003d
cPearson χ^2 test, dMann-Whitney U test.
PSQI - pittsburgh sleep quality index, RLS - restless legs syndrome.
fatigue were more common in CRF patients with RLS 
than those without RLS. Being female, a low ferritin 
level and elevated CRP levels were associated with an 
increased likelihood of RLS.
Identification of RLS in patients undergoing dialysis 
is clinically important, as the presence of RLS has been 
found to be associated with a significantly increased 
rate of cardiovascular risk and mortality.12 Additionally, 
RLS was reported to be related to low quality of life and 
increased risk of death in dialysis patients.16
Globally, the reported prevalence of RLS in dialysis 
patients varies significantly from 6.6% to 70%.4,13,15 
Patients with RLS are more likely to have diabetes and 
hypertension,7 and they are more likely to be female.8 
However, some other studies failed to observe a link 
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between diabetes, hypertension, gender, and RLS.12,25 
In Turkey, similar to the global figures, the reported 
frequency of RLS among CRF patients ranges from 
percentages as low as 3.19%,14 to percentages as high 
as 45.9%.9 In the current study, 16.8% of our CRF 
patients had RLS, with the incidence higher among 
female subjects. 
With regard to symptoms, it is noteworthy to 
observe that severe symptoms have been reported in a 
significant proportion of RLS patients, such as 36.1% 
in one study,12 and 40.2%,13 in another. Similar to the 
published data, 46.4% of our CRF patients with RLS 
had severe to very severe symptoms. Again, based on 
our results, weight, duration of dialysis, anuria, iron, 
TIBC, calcium and TSAT were associated with RLS 
symptom severity. Furthermore, the scores in the RLS 
severity scale correlated with sleep disturbance. 
Many previous studies found a more increased 
incidence of comorbid conditions, such as DM and 
hypertension, in dialysis patients with RLS than in 
those without RLS,7,13,15 while one study failed to 
identify such a relationship.12 In our study, the 2 groups 
had comparable rates of hypertension and diabetes. 
According to our analyses, cigarette smoking and coffee 
consumption were not associated with RLS in CRF 
patients. However, it should be noted that controversial 
results have been obtained in previous studies examining 
the association between RLS and cigarette smoking and 
coffee consumption, with some studies reporting an 
association,11,15 as compared to those finding no such 
association.12 Again, tea consumption was found to be 
unrelated to the development of RLS as was found in 
another study.15 
In a study involving HD patients, in addition to a 
significant association between iron deficiency anemia 
and RLS, the subgroup of subjects with RLS were also 
found to have significantly lower hemoglobin levels.6 
Conversely, other authors could not observe any 
associations of RLS with iron deficiency or anemia.8,12 
It has also been found that iron deficiency, even in the 
absence of anemia, may lead to RLS (Scherer(. While 
Saraji et al did not observe any relationship between 
serum ferritin and RLS, they did detect an association 
with serum hemoglobin.15 Although laboratory 
parameters in the 2 groups of our study were comparable 
other than for albumin, ferritin levels emerged as a 
determinant of the presence of RLS. Moreover, with 
respect to a variety of laboratory parameters, Zaware et 
al,4 did not find any associations of RLS with age, urea, 
creatinine, calcium, potassium, phosphorus, iron or 
ferritin, while Araujo et al,26 found that RLS patients had 
lower hemoglobin, albumin and alkaline phosphatase. 
A positive association with phosphate was reported in 
one study, with opposite findings in another.3,13 In the 
present study, only albumin levels were significantly 
lower among RLS patients, and despite lower iron levels, 
the difference was not significant. Because a reduced 
albumin level may represent a state of malnutrition, the 
levels of the albumin could be low in HD and also RLS 
patients.27 Ferritin was also comparable, although it was 
an independent factor for the development of RLS. 
Sleep disorder is a common finding in patients 
with chronic renal failure, affecting 40%-61%.12,16 
Restless legs syndrome has been reported to represent 
an important cause of sleep disturbance and disease 
morbidity in this population.4 Lin et al,13 reported that 
HD patients with RLS have higher PSQI scores and 
lower sleep quality. Difficulty in sleep-onset in patients 
with RLS was greater than non- RLS group (sleep 
latency more than 60 minutes: 52.1% versus 45.1%(. 
Sleep disturbance was more severe in RLS group 
(34.6% versus 16.8%(. Daytime dysfunction was also 
greater in RLS group (6.3% versus 0.7%(.13 Zaware et 
al4 reported a significant relationship between RLS and 
insomnia severity index. Rohani et al found that sleep 
disturbance was 88% in dialysis patients with RLS. In 
the same study, short sleep duration, insomnia, use of 
sleep medications and daytime insomnia were found 
more frequently in patients with RLS.12 Female RLS 
patients experienced a more pronounced reduction in 
Table 5 - Factors affecting the presence of RLS.
Variables Univariate logistic regression analysis
OR 95% CI P-value
Gender 0.435 [0.206 -0.918] 0.029
PSQI 1.402 [1.261 – 1.559] <0.001
Fatigue scale 1.038 [1.012 – 1.065] 0.004
Ferritine 1.002 [1.000 – 1.003] 0.009
CRP 1.021 [1.021 – 1.039] 0.020
PSQI - pittsburgh sleep quality index, CRP - C reactive protein, OR - 
odds ratio, CI - confidence interval.
Table 6 - Factors affecting the presence of RLS.
Variables Multivariate logistic regression analysis
OR 95% CI P-value
Constant 0.069 0.040
Age 1.022 [0.987-1.058] 0.215
BMI 0.983 [0.916-1.056] 0.642
CRP 1.019 [1.001-0.037] 0.034
BMI - body mass index, CRP - C reactive protein, OR - odds ratio, 
CI - confidence interval. -2log likelihood = 165.433
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sleep quality, while male patients with RLS had more 
daytime sleepiness.5,26 In our study, 91.9% of our RLS 
patients had poor sleep quality, as compared to 39.9% 
in those without RLS (PSQI >5(. Also, patients with 
RLS had worse PSQI sub-scale scores (subjective sleep 
quality, sleep latency, sleep duration, habitual sleep 
activity, sleep disturbance, use of sleep medications and 
daytime dysfunction(.
Published studies examining fatigue in CRF 
patients with RLS are scarce. In a study by Giannak 
et al,28 involving 85 dialysis patients, RLS patients 
reported more severe fatigue, with positive correlations 
between the RLS severity scale and the fatigue index. 
When one considers that many HD patients experience 
intense fatigue symptoms,29 it becomes clear that 
effective treatment of RLS, which contributes to fatigue 
symptoms, may help reduce the severity of fatigue.28 On 
the other hand, despite the presence of studies reporting 
the positive effects of exercise training on fatigue in HD 
patients, none specifically investigated patients with 
RLS.29 Future studies may provide valuable insights 
on the effects of exercise in uremic patients with RLS. 
In our study, RLS patients reported higher levels of 
fatigue, which were also associated with sleep latency 
and daytime dysfunction. 
In conclusion, RLS is a prevalent condition in 
patients undergoing HD, and the results of this study 
appear to confirm that RLS has adverse effects on sleep 
quality and fatigue. Further studies are warranted to 
examine the long-term effects of interventions targeting 
sleep disturbance and fatigue in uremic RLS patients in 
order to determine their contribution to quality of life 
in this group of subjects.
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